Monotherapy efficacy of blood-brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma.

Merisaari, Joni; Denisova, Oxana V; Doroszko, Milena; Le Joncour, Vadim; Johansson, Patrik; Leenders, William P J; Kastrinsky, David B; Zaware, Nilesh; Narla, Goutham; Laakkonen, Pirjo; Nelander, Sven; Ohlmeyer, Michael; Westermarck, Jukka.

Afiliación

Merisaari J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland.
Denisova OV; Institute of Biomedicine, University of Turku, Turku 20520, Finland.
Doroszko M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland.
Le Joncour V; Department of Immunology Genetics and Pathology, Uppsala University, Uppsala 751 85, Sweden.
Johansson P; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
Leenders WPJ; Department of Immunology Genetics and Pathology, Uppsala University, Uppsala 751 85, Sweden.
Kastrinsky DB; Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Nijmegen 6525, The Netherlands.
Zaware N; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Narla G; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.
Laakkonen P; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Nelander S; Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109-5624, USA.
Ohlmeyer M; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
Westermarck J; Laboratory Animal Centre, Helsinki Institute of Life Science - HiLIFE, University of Helsinki, Helsinki 00014, Finland.